Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David A Stevenson

Showing results (131-140 of 167) with videos related to

Pageof 17
Sort By:
American Journal of Human Genetics|August 27, 2013
BMP9 mutations cause a vascular-anomaly syndrome with phenotypic overlap with hereditary hemorrhagic telangiectasiaWhitney L Wooderchak-Donahue, Jamie McDonald, Brendan O'Fallon, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|June 17, 2014
Neurofibromin deficiency-associated transcriptional dysregulation suggests a novel therapy for tibial pseudoarthrosis in NF1Nandina Paria, Tae-Joon Cho, In Ho Choi, et al.
American Journal of Medical Genetics. Part A|July 15, 2026
SHOC2 Is a Novel Cause of Central Conducting Lymphatic AnomalyJessica C Ding, Benjamin A Sempowski, Lola Zerbib, et al.
Molecular Genetics & Genomic Medicine|December 22, 2020
Missense variants in CTNNB1 can be associated with vitreoretinopathy-Seven new cases of CTNNB1-associated neurodevelopmental disorder including a previously unreported retinal phenotypeLinda Z Rossetti, Mir Reza Bekheirnia, Andrea M Lewis, et al.
American Journal of Medical Genetics. Part A|June 22, 2019
Costello syndrome: Clinical phenotype, genotype, and management guidelinesKaren W Gripp, Lindsey A Morse, Marni Axelrad, et al.
Plos One|January 28, 2014
Multiscale, converging defects of macro-porosity, microstructure and matrix mineralization impact long bone fragility in NF1Jirko Kühnisch, Jong Seto, Claudia Lange, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|August 7, 2015
Maternal uniparental disomy of chromosome 20: a novel imprinting disorder of growth failureSurabhi Mulchandani, Elizabeth J Bhoj, Minjie Luo, et al.
Journal of Pediatric Orthopedics|March 14, 2013
Approaches to treating NF1 tibial pseudarthrosis: consensus from the Children's Tumor Foundation NF1 Bone Abnormalities ConsortiumDavid A Stevenson, David Little, Linlea Armstrong, et al.
Plos Genetics|May 20, 2016
The Splicing Efficiency of Activating HRAS Mutations Can Determine Costello Syndrome Phenotype and Frequency in CancerAnne-Mette Hartung, Jeff Swensen, Inaki E Uriz, et al.
American Journal of Medical Genetics. Part A|April 25, 2017
The path forward: 2015 International Children's Tumor Foundation conference on neurofibromatosis type 1, type 2, and schwannomatosisJaishri O Blakeley, Annette Bakker, Anne Barker, et al.
Pageof 17

Showing results (131-140 of 167) with videos related to

Sort By:
Pageof 17
American Journal of Human Genetics|August 27, 2013
BMP9 mutations cause a vascular-anomaly syndrome with phenotypic overlap with hereditary hemorrhagic telangiectasiaWhitney L Wooderchak-Donahue, Jamie McDonald, Brendan O'Fallon, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|June 17, 2014
Neurofibromin deficiency-associated transcriptional dysregulation suggests a novel therapy for tibial pseudoarthrosis in NF1Nandina Paria, Tae-Joon Cho, In Ho Choi, et al.
American Journal of Medical Genetics. Part A|July 15, 2026
SHOC2 Is a Novel Cause of Central Conducting Lymphatic AnomalyJessica C Ding, Benjamin A Sempowski, Lola Zerbib, et al.
Molecular Genetics & Genomic Medicine|December 22, 2020
Missense variants in CTNNB1 can be associated with vitreoretinopathy-Seven new cases of CTNNB1-associated neurodevelopmental disorder including a previously unreported retinal phenotypeLinda Z Rossetti, Mir Reza Bekheirnia, Andrea M Lewis, et al.
American Journal of Medical Genetics. Part A|June 22, 2019
Costello syndrome: Clinical phenotype, genotype, and management guidelinesKaren W Gripp, Lindsey A Morse, Marni Axelrad, et al.
Plos One|January 28, 2014
Multiscale, converging defects of macro-porosity, microstructure and matrix mineralization impact long bone fragility in NF1Jirko Kühnisch, Jong Seto, Claudia Lange, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|August 7, 2015
Maternal uniparental disomy of chromosome 20: a novel imprinting disorder of growth failureSurabhi Mulchandani, Elizabeth J Bhoj, Minjie Luo, et al.
Journal of Pediatric Orthopedics|March 14, 2013
Approaches to treating NF1 tibial pseudarthrosis: consensus from the Children's Tumor Foundation NF1 Bone Abnormalities ConsortiumDavid A Stevenson, David Little, Linlea Armstrong, et al.
Plos Genetics|May 20, 2016
The Splicing Efficiency of Activating HRAS Mutations Can Determine Costello Syndrome Phenotype and Frequency in CancerAnne-Mette Hartung, Jeff Swensen, Inaki E Uriz, et al.
American Journal of Medical Genetics. Part A|April 25, 2017
The path forward: 2015 International Children's Tumor Foundation conference on neurofibromatosis type 1, type 2, and schwannomatosisJaishri O Blakeley, Annette Bakker, Anne Barker, et al.
Pageof 17